Lazard (LAZ) delivered earnings and revenue surprises of +18.08% and +10.12%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Coeur Mining and Hecla Mining are riding strong gold and silver prices, with record Q3 results, rising cash flow and active project pipelines heading into 2026.
Johnson & Johnson leads Zacks latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major and micro-cap stocks.
Dow Inc. (DOW) delivered earnings and revenue surprises of +26.85% and -0.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Honeywell International (HON) delivered earnings and revenue surprises of +2.50% and -2.94%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Trane Technologies (TT) delivered earnings and revenue surprises of +1.24% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Group 1 Automotive (GPI) delivered earnings and revenue surprises of -9.25% and -1.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Ameriprise (AMP) delivered earnings and revenue surprises of +5.27% and +4.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Wix.com (WIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Southside Bancshares (SBSI) delivered earnings and revenue surprises of -12.50% and -9.58%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher (TMO) delivered earnings and revenue surprises of +2.13% and +2.28%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
PulteGroup (PHM) delivered earnings and revenue surprises of +3.53% and +6.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Valero Energy (VLO) delivered earnings and revenue surprises of +18.57% and +8.24%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Caterpillar (CAT) delivered earnings and revenue surprises of +10.41% and +6.60%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Royal Caribbean (RCL) delivered earnings and revenue surprises of -0.29% and -0.24%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Energy Fuels (UUUU) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Eagle Materials (EXP) delivered earnings and revenue surprises of -2.92% and +0.36%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Despite evolving political views, regulatory recalibration and market volatility, sustainable investing has shown resilience rather than retreat over the past year, with growth shifting geographically and adaptation emerging as a critical new frontier for investors, according to Jaakko Kooroshy, global head sustainable investment research at LSEG.
Open source powers critical systems, yet is undervalued and exposed. The 2026 State of the Software Supply Chain report reveals why this disconnect is risky.
Der von Elon Musk geführte Konzern Tesla leidet unter der rückläufigen Nachfrage nach seinen E-Autos. Der Umsatz ging im vergangenen Jahr spürbar zurück. Die Produktion zweier Modelle soll eingestellt werden.
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Companys issued and outstanding common shares. As previously disclosed, the Company’s Board of Directors approved a reverse stock split at a ratio of 1-for-6.25, which was intended to become effective at the opening of the market on January 20, 2026, however, following furthe...